Australia is gain access to potentially transformative treatment for excess weight: Retatrutide. The dual compound – working on both GLP-1 and GIP receptors – demonstrates significant efficacy in clinical studies, pointing to meaningful reductions in weight. While availability remains with the Therapeutic Goods Administration (TGA), a number of… Read More